Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for Orthofix Medical (OFIX) over the last 16 years, with Q3 2025 value amounting to $108.6 million.

  • Orthofix Medical's Other Accumulated Expenses rose 67.6% to $108.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $108.6 million, marking a year-over-year increase of 67.6%. This contributed to the annual value of $119.1 million for FY2024, which is 1349.94% up from last year.
  • Latest data reveals that Orthofix Medical reported Other Accumulated Expenses of $108.6 million as of Q3 2025, which was up 67.6% from $102.5 million recorded in Q2 2025.
  • In the past 5 years, Orthofix Medical's Other Accumulated Expenses registered a high of $119.1 million during Q4 2024, and its lowest value of $48.2 million during Q2 2022.
  • Moreover, its 5-year median value for Other Accumulated Expenses was $89.8 million (2023), whereas its average is $83.8 million.
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first crashed by 2788.06% in 2022, then skyrocketed by 10114.68% in 2023.
  • Quarter analysis of 5 years shows Orthofix Medical's Other Accumulated Expenses stood at $76.8 million in 2021, then fell by 27.88% to $55.4 million in 2022, then skyrocketed by 89.45% to $104.9 million in 2023, then grew by 13.5% to $119.1 million in 2024, then decreased by 8.81% to $108.6 million in 2025.
  • Its Other Accumulated Expenses was $108.6 million in Q3 2025, compared to $102.5 million in Q2 2025 and $98.2 million in Q1 2025.